DEN210014 is an FDA 510(k) submission (not cleared) for the EaseVRx. Classified as Virtual Reality Behavioral Therapy Device For Pain Relief (product code QRA), Class II - Special Controls.
Submitted by Appliedvr, Inc. (Van Nuys, US). The FDA issued a Not Cleared (DENG) decision on November 16, 2021 after a review of 231 days.
This device falls under the Physical Medicine FDA review panel, regulated under 21 CFR 890.5800 - the FDA physical medicine device framework. The Traditional 510(k) pathway requires demonstration of substantial equivalence to a legally marketed predicate device - a standard the FDA determined was not met in this submission.
Device pattern: High-complexity regulatory submission. Elevated predicate reliance profile. This submission did not achieve clearance, indicating the FDA determined the device lacked sufficient predicate equivalence under the Physical Medicine review framework.
View all Appliedvr, Inc. devices